Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29
Frequently Asked Questions
What is Market Cap of Palvella Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Palvella Therapeutics Inc. market cap is $1.67B.
What is the 52-week high for Palvella Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Palvella Therapeutics Inc. 52 week high is $151.18 as of June 17, 2026.
What is the 52-week low for Palvella Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Palvella Therapeutics Inc. 52 week low is $20.20 as of June 17, 2026.
What is Palvella Therapeutics Inc. stock price today?
Palvella Therapeutics Inc. stock price today is $110.12.
What was Palvella Therapeutics Inc. stock price yesterday?
Palvella Therapeutics Inc. stock price yesterday was $116.51.
What is the PE ratio of Palvella Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Palvella Therapeutics Inc.'s P/E ratio is -26.42.
What is the Price-to-Book ratio of Palvella Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Palvella Therapeutics Inc. P/B ratio is 7.4603.
What is the 50-day moving average of Palvella Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Palvella Therapeutics Inc. 50-day moving average is $119.53.
How many employees does Palvella Therapeutics Inc. have?
